MENU
AGIO
AS OF
Feb 4, 02:26 PM (EDT)
Price
$27.85
Change
-$0.08 (-0.29%)
Capitalization
1.63B
8 days until earnings call
Intraday BUY SELL Signals
+Compare
AGIO
Stock ticker: NASDAQ
AS OF
Feb 4, 02:26 PM (EDT)
Price
$27.85
Change
-$0.08 (-0.29%)
Capitalization
1.63B

AGIO Agios Pharmaceuticals Forecast, Technical & Fundamental Analysis

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology... Show more

Industry: #Biotechnology
AGIO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for AGIO with price predictions
Feb 03, 2026

Momentum Indicator for AGIO turns positive, indicating new upward trend

AGIO saw its Momentum Indicator move above the 0 level on February 02, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 100 similar instances where the indicator turned positive. In of the 100 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

AGIO moved above its 50-day moving average on February 02, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AGIO crossed bullishly above the 50-day moving average on January 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AGIO advanced for three days, in of 287 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 212 cases where AGIO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 72 cases where AGIO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The 50-day moving average for AGIO moved below the 200-day moving average on December 26, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AGIO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.268) is normal, around the industry mean (27.519). P/E Ratio (3.821) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (36.232) is also within normal values, averaging (331.843).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AGIO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AGIO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
AGIO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

AGIO is expected to report earnings to rise 9.55% to -195 cents per share on February 12

Agios Pharmaceuticals AGIO Stock Earnings Reports
Q4'25
Est.
$-1.95
Q3'25
Beat
by $0.12
Q2'25
Missed
by $0.12
Q1'25
Beat
by $0.23
Q4'24
Beat
by $0.24
The last earnings report on October 30 showed earnings per share of -177 cents, beating the estimate of -189 cents. With 83.02K shares outstanding, the current market capitalization sits at 1.63B.
A.I. Advisor
published General Information

General Information

a developer of therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
88 Sidney Street
Phone
+1 617 649-8600
Employees
386
Web
https://www.agios.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MICYX10.490.05
+0.48%
Victory Trivalent Intl Fd-Core Eq Y
ABCSX22.520.05
+0.22%
AB Discovery Value C
BMDIX19.43-0.19
-0.97%
Baird Mid Cap Growth Institutional
OSGIX37.78-0.38
-1.00%
JPMorgan Mid Cap Growth A
LOGSX23.91-0.31
-1.28%
Live Oak Health Sciences

AGIO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AGIO has been loosely correlated with TPST. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AGIO jumps, then TPST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGIO
1D Price
Change %
AGIO100%
-0.82%
TPST - AGIO
56%
Loosely correlated
-2.43%
LGND - AGIO
51%
Loosely correlated
+0.46%
CRNX - AGIO
46%
Loosely correlated
+1.24%
AVBP - AGIO
46%
Loosely correlated
-0.15%
AXON - AGIO
45%
Loosely correlated
-1.89%
More